Journal of Nephrology & Renal DiseasesISSN: 2576-3962

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

https://sporbahisleri.livejournal.com https://wakelet.com/@SporBahisleri67459 https://theomnibuzz.com/author/sporbahisleri/ https://lessons.drawspace.com/profile/322207/sporbahisleri/workflow https://writeupcafe.com/profile/sporbahisleri/ http://www.pearltrees.com/sporbahisleri https://pharmahub.org/members/26874/blog https://www.zupyak.com/u/Spor-Bahisleri/ https://www.metroflog.co/sporbahisleri https://www.fuzia.com/fz/spor-bahisleri https://tr.pinterest.com/sporbahislerim/ https://my.getjealous.com/sporbahisleri https://sporbahisleri.contently.com https://hubpages.com/@sporbahisleri https://www.tumblr.com/sporbahisleri https://hub.docker.com/u/sporbahislerim https://betsiteleri.blogfree.net https://betsiteleri.amebaownd.com https://sporbahisleri.pixnet.net/blog https://betsiteleri.seesaa.net https://betsiteleri.threadless.com https://betsiteleri.neocities.org https://bahissiteleri.localinfo.jp https://betsiteleri.shopinfo.jp https://teletype.in/@betsiteleri https://ubl.xml.org/users/sporbahisleri https://betsiteleri.educatorpages.com https://betsiteleri.onlc.fr https://sporbahisleri.gumroad.com

Hormonal therapy in women: Renal adverse effects

Chronic Kidney Disease (CKD) is commonly associated with menstrual disorders, infertility, and premature menopause. Nephrologists are often considered as the primary care providers by their patients, but perceptions of nephrologists on management of these issues are currently unknown. Studies proved there was a high level of uncertainty among Nephrologists with regard to the role of Hormonal Therapy (HT) in women with CKD. Primary ovarian function appears to be preserved in the setting of CKD, ovulatory and menstrual irregularities observed in the CKD are likely to be the consequence of hypothalamic and pituitary, rather than ovarian. Increases renal tubular responsiveness to changes in sodium intake leading to an increased GFR and filtration fraction, an increase in renal nitric oxide and an increase in Renin–Angiotensin Activity (RAS), which has been linked to a greater risk of diabetic nephropathy while hormonal replacement therapy was associated with a 19% reduction in ACR (P=0.008) and an odds ratio of 0.67 (95% confidence interval, 0.43 to 1.01; P=0.06).

Special Features

Full Text

View

Track Your Manuscript

Media Partners

GET THE APP